AINDEX
Markets

Penumbra, Inc. (PEN)

PENNYSEMedical/Dental Instruments

$321.46

-0.3900 (-0.12%) today

At the close, Nov 10, 4:00 PM ET. After hours $321.46 +0.02%

-0.12% 1D
Market cap
$12.67bn
P/E
81.4
EPS, last 4 quarters
$3.95
Dividend yield
–
Day range
$320.21 to $321.60
52-week range
$262.94 to $362.41
Average volume
312.4k
Previous close
$321.85

Analysts

2 covering

Hold0 buy, 2 hold, 0 sell

Targets a year out average $362.00, +12.6% from here

$350.00now $321.46$374.00

Earnings

Next report

Dec 2025

+5.4%

Mar 2026

-26.1%

Jun 2026

-23.5%

Sep 2026

–

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$385.38m$374.76m$390.05m$410.14m
Gross profit$262.13m$253.41m$264.94m$280.30m
Operating income$59.23m$38.23m$41.04m$50.74m
Net income$47.34m$32.58m$34.81m$42.28m

Last four quarters: revenue $1.56bn, margin 10.1%, free cash flow $200.29m

News

8 latest

The company

Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.